These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 18827910)

  • 1. Cardiovascular co-morbidity in rheumatic diseases.
    Turesson C; Jacobsson LT; Matteson EL
    Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases.
    Turesson C; Matteson EL
    Curr Opin Rheumatol; 2007 Mar; 19(2):190-6. PubMed ID: 17278937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Cardiovascular Risk in Patients with Rheumatic Disease.
    Ferguson LD; Sattar N; McInnes IB
    Rheum Dis Clin North Am; 2022 May; 48(2):429-444. PubMed ID: 35400369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
    Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
    Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.
    Symmons DP; Gabriel SE
    Nat Rev Rheumatol; 2011 May; 7(7):399-408. PubMed ID: 21629241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular co-morbidity in patients with rheumatic diseases.
    Frostegård J
    Arthritis Res Ther; 2011 Jun; 13(3):225. PubMed ID: 21722331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Cardiovascular Risk in Patients with Rheumatic Disease.
    Ferguson LD; Sattar N; McInnes IB
    Med Clin North Am; 2021 Mar; 105(2):247-262. PubMed ID: 33589100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatic diseases as risk factors for cardiovascular disease].
    Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):305-15. PubMed ID: 20080915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases.
    Mackey RH; Kuller LH; Moreland LW
    Rheum Dis Clin North Am; 2018 Aug; 44(3):475-487. PubMed ID: 30001787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
    Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
    Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory lipids as a target for therapy in the rheumatic diseases.
    McMahon M; Brahn E
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1213-24. PubMed ID: 18616417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
    Abou-Raya A; Abou-Raya S
    Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
    Kerkhof PLM; Khamaganova I
    Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins: immunomodulators for autoimmune rheumatic disease?
    Jury EC; Ehrenstein MR
    Lupus; 2005; 14(3):192-6. PubMed ID: 15807195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Salmon JE; Roman MJ
    Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.